Leap Therapeutics (LPTX)
(Delayed Data from NSDQ)
$2.20 USD
+0.03 (1.38%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.19 -0.01 (-0.45%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Leap Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -81.41 | -54.60 | -40.59 | -27.51 | -32.90 |
Depreciation/Amortization & Depletion | 0.02 | 0.02 | 0.16 | 0.17 | 0.05 |
Net Change from Assets/Liabilities | 2.51 | -0.80 | 1.00 | -0.95 | 1.33 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 35.14 | 6.34 | 4.26 | 2.34 | 4.62 |
Net Cash From Operating Activities | -43.75 | -49.04 | -35.16 | -25.96 | -26.90 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.03 | -0.09 |
Acquisition/ Disposition of Subsidiaries | 50.36 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -1.39 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 48.97 | 0.00 | 0.00 | 0.03 | -0.09 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.03 | 0.00 | 98.22 | 75.90 | 15.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.21 | -0.18 | -1.91 | -0.44 |
Net Cash from Financing Activities | -0.03 | -0.21 | 98.04 | 74.00 | 14.82 |
Effect of Exchange Rate Changes | -0.04 | -0.16 | -0.03 | 0.12 | -0.22 |
Net Change In Cash & Equivalents | 5.14 | -49.42 | 62.85 | 48.18 | -12.39 |
Cash at Beginning of Period | 65.50 | 114.92 | 52.07 | 3.89 | 16.28 |
Cash at End of Period | 70.64 | 65.50 | 114.92 | 52.07 | 3.89 |
Diluted Net EPS | -3.98 | -4.80 | -4.70 | -6.30 | -14.70 |
Fiscal Year End for Leap Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -13.82 | -81.41 | -68.95 | -55.25 |
Depreciation/Amortization & Depletion | NA | 0.01 | 0.02 | 0.01 | 0.21 |
Net Change from Assets/Liabilities | NA | -3.07 | 2.51 | 0.85 | -0.45 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.36 | 35.14 | 34.72 | 32.61 |
Net Cash From Operating Activities | NA | -15.52 | -43.75 | -33.37 | -22.89 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 50.36 | 50.36 | 50.36 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | -1.39 | -1.39 | -1.39 |
Net Cash from Investing Activities | NA | 0.00 | 48.97 | 48.97 | 48.97 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.03 | -0.03 | -0.03 | -0.03 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.03 | -0.03 | -0.03 | -0.03 |
Effect of Exchange Rate Changes | NA | -0.24 | -0.04 | -0.32 | -0.14 |
Net Change In Cash & Equivalents | NA | -15.72 | 5.14 | 15.24 | 25.92 |
Cash at Beginning of Period | NA | 70.64 | 65.50 | 65.50 | 65.50 |
Cash at End of Period | NA | 54.92 | 70.64 | 80.74 | 91.42 |
Diluted Net EPS | NA | -0.51 | 0.64 | -0.51 | -0.91 |